Topic: semaglutide
Clinical
NHSE medical director 'alarmed' by reports of inappropriate weight loss drug use
14th June 2024
Clinical
NICE recommends tirzepatide for NHS primary care
7th June 2024
Cardiovascular
Semaglutide helps heart failure symptoms in patients with obesity and type 2 diabetes
23rd April 2024
Clinical
GLP-1 receptor agonists not linked to suicidal thoughts, PRAC concludes
17th April 2024
Clinical
Diabetes drug shows potential in treating Parkinson’s disease
15th April 2024
Clinical
Notification issued for multiple GLP1-RA shortages
19th March 2024
Clinical
Mounjaro weight loss service hoped to ease supply issues
16th February 2024
Clinical
Patients hospitalised from 'potentially fake' weight-loss pens
30th October 2023
Community
MHRA finds fake Ozempic pens in UK supply chain
20th October 2023
Clinical
Tirzepatide approval sparks hope though supply warnings remain
11th September 2023
Clinical
‘No known’ Wegovy supply issues, says DHSC
5th September 2023
Clinical
‘Controlled and limited launch’ of Wegovy from today
4th September 2023
Cardiovascular
Semaglutide cuts risk of cardiovascular events by 20%, claims manufacturer
9th August 2023
Clinical
Regulators issue statement on GLP-1 RA prescribing
20th July 2023
Clinical
Pharmacists and GPs call for diabetes drug supply protection
11th July 2023
Clinical
GLP-1 receptor agonists shortage expected until 2025
4th July 2023
